Filing Details
- Accession Number:
- 0001181431-11-018351
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-16 13:56:03
- Reporting Period:
- 2011-03-15
- Filing Date:
- 2011-03-16
- Accepted Time:
- 2011-03-16 13:56:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178711 | Transcept Pharmaceuticals Inc | TSPT | Pharmaceutical Preparations (2834) | 330960223 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1235962 | E Marilyn Wortzman | C/O Transcept Pharmaceuticals, Inc. 1003 W. Cutting Blvd, Suite 110 Point Richmond CA 94804 | Vp, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-03-15 | 4,000 | $1.77 | 4,217 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-03-15 | 4,000 | $8.17 | 217 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2011-03-15 | 4,000 | $0.00 | 4,000 | $1.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,027 | 2017-04-04 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2010.
- The sale price reported in column 4 of Table 1 represents the weighted average sales price of the shares sold ranging from $8.08 to $8.22 per share. Upon request of the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
- One-fourth of the shares subject to the option vested on March 16, 2008 and one forty-eighth of the shares shall vest monthly thereafter.
Billionaire Hedge Funds
